Understanding High Blood Pressure

Let’s put it in dramatic terms: if high blood pressure were a character in a story, it would be the quiet neighbor who turns out to be a serial killer. It’s subtle, gives no nasty warning signs, and by the time it makes its move, it’s probably too late to prevent any damage. Now, perhaps […]
Ozempic, Chronic Kidney Disease, and Diabetes

In January 2025, the FDA approved Ozempic (semaglutide) to help treat patients with chronic kidney disease and diabetes. Semaglutide belongs to a group of drugs called glucagon-like peptide-1 receptor agonists (GLP1-RAs), which were originally approved to help control blood sugar in people with type 2 diabetes. Other forms of GLP1-RAs include Mounjaro, Wegovy, semaglutide, and […]
Cystitis and Bladder Pain Let’s Talk About It
Over the years, we have learned that many people suffer in silence when it comes to bladder problems, especially something as common as mild cystitis (inflammation of the bladder), and only seek professional help when the symptoms become more serious. It’s a condition that may be shrugged off as a minor nuisance, but for those […]
Strong Kidneys, Better Health
March is National Kidney Month, a time to focus on kidney health. In 2025, National Kidney Month will center around the theme “Know Your Kidneys: The Path to Prevention.” The campaign encourages people to understand how the kidneys work, the conditions that can harm them, and the habits that can keep them healthy. Raising awareness […]
Are Your Kidneys OK?
The human body can manage with reduced kidney function for a long time, often without showing any signs. This is why World Kidney Day 2025’s theme is, Are Your Kidneys OK? Detect early and protect kidney health. While chronic kidney disease has no cure, if it is caught early enough, measures can be taken to […]
News: Zepbound (tirzepatide) Approved to Treat Obstructive Sleep Apnea
The weight-loss drug Zepbound is the first FDA-approved prescription medicine to help treat obstructive sleep apnea (OSA). Zepbound, or tirzepatide, originally received approval in November 2023 to treat obesity. It’s now a new rival to Novo Nordisk’s popular drug, Wegovy. The FDA has now given the green light for tirzepatide to treat obstructive sleep apnea […]
Coming to Terms With Chronic Kidney Disease
Chronic kidney disease (CKD) is one of the main contributors to premature mortality worldwide. It is important to recognize the unfortunate reality that CKD is incurable. There are (currently) no long-term medication solutions to slow down or stop its progression. In this sense, kidney disease is different from other life-threatening diseases such as heart failure, […]